ABSTRACT
Background Prediction of which traumatic and hypoxic brain injuries will progress to brain death is currently based predominantly on history, physical examination and radiographic findings. We investigated how accurately purely objective measures including three neurologic serum markers and algorithmic CT (computed tomograph) scan analysis can predict brain death and differentiate its etiology.
Methods This prospective observational study enrolled 51 isolated trauma subjects and 19 clinically brain dead subjects that were further divided by mechanism of injury into high-velocity trauma with presumed diffuse axonal injury, cardiopulmonary/respiratory arrest, and found down groups. Levels of glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and S100 Calcium-Binding Protein B (S100B) were compared, and algorithmic analysis of CT scan imaging was performed using an open-source deep learning software (BLAST-CT).
Findings The prognostic value of various biomarker combinations in identifying subjects progressing to brain death was assessed using machine learning. Prediction accuracy for GFAP, UCH-L1, and S100B and algorithmic CT analysis in combination to predict brain death from among all other cohorts yielded an area under the receiver operator curve of 0.98 versus all other brain injury subjects. This model was also able to distinguish brain death attributed to cardiopulmonary/respiratory arrest from combined non-trauma controls and diffuse axonal injury with an area under the curve of 0.99.
Interpretation Serum concentrations of GFAP, UCH-L1, and S100B measured within 32 hours of traumatic and hypoxic brain injury (cardiopulmonary/respiratory arrest) and algorithmic CT analysis have utility in prognosticating brain death and predicting its mechanism of injury as either hypoxic or traumatic/unknown (diffuse axonal injury/found down).
Funding Abbott Labs and the Minnesota State Office of Higher Education.
Competing Interest Statement
Dr. Uzma Samadani reports receiving lecture fees from Abbott; the American Association of Neuroscience Nurses; Cottage Health; Google Inc.; Integra Corp; Medtronic Corp; National Neurotrauma Society; Minnesota, Texas, Louisiana, and Wisconsin Coaches Associations; and the National Football League and USA Football. She also reports receiving grant support from the State of Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant Program administered by the Minnesota Office of Higher Education, Veterans Administration, Abbott Laboratories, Medtronic, and Integra. Finally, she reports serving as an unaffiliated neurotrauma consultant to the National Football League for five games during each of the 2015 to 2018 football seasons.
Funding Statement
This study was funded by Abbott Labs and the Minnesota State Office of Higher Education Project Number 176016. Neither played a role in generation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Hennepin Healthcare Institutional Review Board (HSR #15-4079) approved the ethical aspects of the prospective enrollment of patients who presented to the emergency department of the emergency department of the trauma center between May 2016 and April 2017.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
danjamesrafter{at}gmail.com, brettsterk{at}gmail.com, lixx3617{at}umn.edu, schaa033{at}umn.edu, kuang{at}umn.edu, kolle153{at}umn.edu
Added table 5 and new methods including automated CT analysis.
Data Availability
Data will be made available upon reasonable request.